JPMORGAN CHASE & CO - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAE4. A total of 6 filers reported holding PDL BIOPHARMA INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 3.3%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q1 2014$2,158,000
+0.3%
1,400,0000.0%0.00%0.0%
Q4 2013$2,151,000
+6.9%
1,400,0000.0%0.00%0.0%
Q3 2013$2,012,000
+5.7%
1,400,0000.0%0.00%0.0%
Q2 2013$1,903,0001,400,0000.00%
Other shareholders
PDL BIOPHARMA INC shareholders Q1 2014
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 25,974,000$40,197,00019.49%
WOLVERINE ASSET MANAGEMENT LLC 17,710,000$27,332,0000.58%
UBS AG 2,700,000$4,161,0000.00%
DEUTSCHE BANK AG\ 475,000$731,0000.00%
Jefferies Group LLC 52,000$80,0000.00%
JPMORGAN CHASE & CO 1,400,000$2,158,0000.00%
View complete list of PDL BIOPHARMA INC shareholders